Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sensulin, LLC
The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.
This Month's Profile Group: Heightened Concussion Awareness Calls For New Detection Tools, features profiles of Cerora, MC10, Oculogica, and Sway Medical. Plus these Start-Ups Across Health Care: Bicycle Therapeutics, Crosstrees Medical, Rescue Therapeutics, and Sensulin.
Sensulin LLC aims to treat diabetes by linking a liposome-encapsulated form of recombinant human insulin with a boronic-acid derivative that is a competitive binder with glucose. If the drug works as envisioned, it would reduce the risk of hypoglycemia that can occur when glucose levels fluctuate during the day, and would also obviate the need for multiple injections and constant monitoring.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.